Enliven Therapeutics, Inc. (ELVN)
54.32
-1.91
(-3.40%)
USD |
NASDAQ |
Sep 11, 16:00
54.29
-0.03
(-0.06%)
After-Hours: 20:00
Enliven Therapeutics Market Cap : 3.979B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 3.979B |
| September 10, 2026 | 4.119B |
| September 09, 2026 | 4.208B |
| September 08, 2026 | 4.349B |
| September 04, 2026 | 4.345B |
| September 03, 2026 | 4.369B |
| September 02, 2026 | 4.323B |
| September 01, 2026 | 4.238B |
| August 31, 2026 | 4.241B |
| August 28, 2026 | 4.238B |
| August 27, 2026 | 4.432B |
| August 26, 2026 | 4.458B |
| August 25, 2026 | 4.469B |
| August 24, 2026 | 4.479B |
| August 21, 2026 | 4.382B |
| August 20, 2026 | 4.316B |
| August 19, 2026 | 4.350B |
| August 18, 2026 | 4.400B |
| August 17, 2026 | 4.361B |
| August 14, 2026 | 4.309B |
| August 13, 2026 | 4.253B |
| August 12, 2026 | 4.243B |
| August 11, 2026 | 4.306B |
| August 10, 2026 | 4.353B |
| August 07, 2026 | 4.429B |
| Date | Value |
|---|---|
| August 06, 2026 | 4.415B |
| August 05, 2026 | 4.373B |
| August 04, 2026 | 4.476B |
| August 03, 2026 | 4.252B |
| July 31, 2026 | 3.337B |
| July 30, 2026 | 3.285B |
| July 29, 2026 | 3.225B |
| July 28, 2026 | 3.273B |
| July 27, 2026 | 3.211B |
| July 24, 2026 | 3.224B |
| July 23, 2026 | 3.216B |
| July 22, 2026 | 3.218B |
| July 21, 2026 | 3.308B |
| July 20, 2026 | 3.146B |
| July 17, 2026 | 3.239B |
| July 16, 2026 | 3.097B |
| July 15, 2026 | 3.237B |
| July 14, 2026 | 3.150B |
| July 13, 2026 | 3.097B |
| July 10, 2026 | 3.111B |
| July 09, 2026 | 3.177B |
| July 08, 2026 | 3.093B |
| July 07, 2026 | 3.101B |
| July 06, 2026 | 3.045B |
| July 02, 2026 | 3.034B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cocrystal Pharma, Inc. | 17.10M |
| CNBX Pharmaceuticals, Inc. | 0.1476M |
| GB Sciences, Inc. | 0.0814M |
| Arvinas, Inc. | 551.78M |
| Fulcrum Therapeutics, Inc. | 289.88M |
Market Cap Related Metrics
| Price to Book Value | 4.445 |
| Price | 54.32 |
| Earnings Yield | -3.07% |